Improvements in patient-reported outcomes: A prospective, non-interventional study with aclidinium bromide for treatment of COPD.

Trial Profile

Improvements in patient-reported outcomes: A prospective, non-interventional study with aclidinium bromide for treatment of COPD.

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Nov 2015

At a glance

  • Drugs Aclidinium bromide (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Acronyms A NEED
  • Sponsors Almirall S.A.
  • Most Recent Events

    • 06 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top